Sarepta Therapeutics

Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 36.58M 92.63M 2023-12
Agios Pharmaceuticals USD -104874000 5.6M 2023-12
Alnylam Pharmaceuticals USD -102922000 330.12M 2023-12
Amgen USD 3.66B 713M 2023-12
Avrobio USD -21091000 5.65M 2023-09
BioMarin Pharmaceutical USD 55.08M 3.73M 2023-12
Daiichi Sankyo JPY 65.42B 7.22B 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
Gilead Sciences USD 2.73B 579M 2023-12
Incyte USD 226.99M 9.73M 2023-12
Insmed USD -159156000 23.92M 2023-12
Ionis Pharmaceuticals USD -2924000 137.16M 2023-12
Moderna USD 209M 1.97B 2023-12
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pfizer USD 1.14B 2.05B 2023-12
PTC Therapeutics USD 88.72M 144.83M 2023-12
Regeneron Pharmaceuticals USD 1.32B 196.8M 2023-09
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD -9914000 112.81M 2023-09
Ultragenyx Pharmaceutical USD -137906000 4.69M 2023-09
Vertex Pharmaceuticals USD 1.08B 12.4M 2023-09



Sarepta Therapeutics - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.